Public Company News
Ping An Launches Home-Based Elderlycare Service to Pursue "Finance + Elderlycare" Business Strategy
HONG KONG and SHANGHAI, March 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that subsidiaryPing An Life has launched an elderly home care service. Building on the strength ofPing An's healthcare ecosy...
2022-03-11 14:47
4857
NetDragon Announces Its Commitment to ESG
HONG KONG, March 10, 2022 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, announced its sustainability visions and disclosed several key policies whilst launching its brand-new ESG webs...
2022-03-11 11:53
5035
Tiger Trade downloads triple during its Australian debut week
SYDNEY, March 11, 2022 /PRNewswire/ -- The one-stop online investing platform Tiger Trade has more than tripled its downloads inAustralia within its launch week. Tiger Trade has also jumped into the No 9 finance app spot in Google Play Australia this week, showing rapid growth just in few days. T...
2022-03-11 11:36
5306
Yum China Provides Update on Status under Holding Foreign Companies Accountable Act
SHANGHAI, March 11, 2022 /PRNewswire/ – Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) today provided an update on its status under the Holding Foreign Companies Accountable Act (the "Act"). On March 8, 2022, as expected in its implementation of the Act, the U...
2022-03-11 08:15
5797
Gan & Lee Pharmaceuticals Begins First-In-Human Trial in U.S. for Investigational Drug, GZR18
BEIJING and BRIDGEWATER, N.J., March 11, 2022 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce the first subject has been dosed in our Phase I, double-blinded, randomized, placebo-controlled, sequential, sing...
2022-03-11 03:35
4675
Novavax Announces Launch of Global Vaccine Education Programs
- 'We Do Vaccines' and 'Know Our Vax' are new educational efforts that provide information regarding vaccines - Programs explain Novavax' commitment to vaccine development and innovation GAITHERSBURG, Md., March 10, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company de...
2022-03-10 22:00
5086
Bigtincan Wins Silver Stevie® Award for its Sales Enablement Solution
Leader in sales enablement automation takes home 7th Stevie Award for Sales & Customer Service WALTHAM, Mass., March 10, 2022 /PRNewswire/ -- Bigtincan (ASX: BTH), the global leader in sales enablement automation, today announced the company has won a Silver 2022 Stevie® Award for the Sales Enab...
2022-03-10 21:00
3689
BNY Mellon Announces Leadership Succession Plan Naming Robin Vince CEO-Elect
CEO Todd Gibbons to Retire This Year Robin Vince, Vice Chair of BNY Mellon and CEO of Global Market Infrastructure, Named President and CEO-elect NEW YORK, March 10, 2022 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY Mellon") (NYSE: BK) announced today thatThomas P. (Todd) Gibbo...
2022-03-10 20:30
5799
Infineon and Sleepiz enable high-precision sleep monitoring at home based on radar technology
MUNICH, March 10, 2022 /PRNewswire/ -- Billions of people are facing sleep problems. According to scientific research[1], about one billion people alone suffer from sleep apnea, an interrupted breathing during the night. This is leading to various health consequences including snoring, daytime fa...
2022-03-10 19:49
5199
Everest Medicines Announces that Licensing Partner Venatorx Pharmaceuticals Reports Positive Results from Pivotal Phase 3 Cefepime-Taniborbactam Trial
SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Venatorx Pharmaceuticals, reported positive results from its pivotal Phase 3 study, CERTAIN-1 (Cefepime Rescue with Taniborbactam in cUTI), evaluating cefepime-taniborbactam, an in...
2022-03-10 19:05
4481
Infosys Becomes Digital Innovation Partner for International Tennis Hall of Fame and Title Sponsor of the Hall of Fame Open
Strategic collaboration to bring technology expertise to reimagine fan
experiences and preserve tennis heritage at the historic venue where the first
U.S. National Championships were hosted in 1881
NEWPORT, R.I., March 10, 2022 /PRNewswire/ -- Infosys
2022-03-10 18:49
3873
Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families
HONG KONG, March 10, 2022 /PRNewswire/ -- In the face of the severe fifth wave of epidemic inHong Kong, Fosun Foundation quickly launched the epidemic relief work of "Let's Work Hand in Hand and Combat the Epidemic Together" inHong Kong. After the first batch of 250,000 sets of COVID-19 rapid ant...
2022-03-10 14:25
4113
GOODWE CHANGES BRAND GUIDELINE WITH MORE COOPERATION OPPORTUNITIES
HANOI, Vietnam, March 10, 2022 /PRNewswire/ -- On January 7, 2022, GoodWe, the world's leading manufacturer of energy storage solutions and solar inverters, officially changed its brand identity to match the development trend of the renewable energy industry. The core of the rebranding is GoodWe'...
2022-03-10 13:15
4644
SleekFlow, an Alibaba-backed all-in-one social commerce software continues to build a strong team in SEA, seizing upon this era of social distancing
SINGAPORE, March 10, 2022 /PRNewswire/ -- SleekFlow
2022-03-10 10:30
7219
Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma
- The novel bispecific antibody ATG-101 is Antengene's first in house developed molecule with global rights. - This approval in China marks the third regulatory clearance granted to ATG-101 globally. - Upon receiving clearances in Australia and the U.S. in 2021, the Phase I study of ATG-101 ...
2022-03-10 08:52
4831
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress
SUZHOU, China, March 10, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta has ...
2022-03-10 08:30
4316
Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin
Revenue increased in 2021 to $21.8M vs. $4.3M in 2020 2021 second-half revenue increased to $11.7M vs. $3.5M in the second half of 2020 Record Q4 2021 revenues of $8.9M Revenue from pulses for the full year 2021 increased to $2.6M TEL AVIV, Israel, March 9, 2022 /PRNewswire/ -- Mr. Lou Scafuri,...
2022-03-09 23:20
2586
New Tough Off-road Contender--GWM TANK300 Arrives Now
BAODING, China, March 9, 2022 /PRNewswire/ -- Recently, according to the 2021
sales report of GWM, GWM TANK300 has an outstanding market share, accounting
for more than 50% of the tough off-road market inChina.
2022-03-09 21:59
10395
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
BOSTON, LAUSANNE, Switzerland and TAIPEI CITY, Taiwan, March 9, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies inTaiwan aiming to provide genetic testing to clinicians, is the first institution inAsia...
2022-03-09 21:57
3230
New Virtual Selling and Coaching Technologies from Bigtincan Allow Organizations to Bring the Metaverse and Web 3.0 Technologies to Sales Teams and Customers
New Features Dramatically Improve Engagement in Virtual Environments WALTHAM, Mass., March 9, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), the global leader in sales enablement automation, today announced the availability of a set of technologies that allow organizations to bring Metaverse and Web...
2022-03-09 21:00
2030
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
[Picked up by 292 media titles]
2026-07-30 09:12
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
[Picked up by 291 media titles]
2026-07-27 19:02
ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30
Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
9739
Association of Trade and Commerce Reinforces Commitment to Supporting Singapore Enterprises Through Global Growth at The Entrepreneur Singapore 2026
2026-07-31 21:45
8942
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
2026-07-27 19:02
8556
KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
2026-07-30 09:12
8519